These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5492591)

  • 21. [Cryptococcus neoformans infection. Illustrated by a case of meningitis].
    Odegaard A; Steinbakk M; Stavem P
    Tidsskr Nor Laegeforen; 1983 Oct; 103(28):1930-2. PubMed ID: 6648930
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic failure of 5-fluorocytosine in a patient with cryptococcal meningitis and pneumonia.
    Dowell AR; Stibbins DE; Jay AC; List J
    J Indiana State Med Assoc; 1973 Dec; 66(12):1085-8. PubMed ID: 4589050
    [No Abstract]   [Full Text] [Related]  

  • 23. [Candida meningoencephalitis treated with 5-fluorocytosine].
    Nordström L; Oistmö S; Olmebring F
    Lakartidningen; 1977 Jan; 74(3):135-6. PubMed ID: 831044
    [No Abstract]   [Full Text] [Related]  

  • 24. Systemic candidiasis in an infant treated with 5-fluorocytosine.
    Burnell RH
    Med J Aust; 1971 Oct; 2(17):859-60. PubMed ID: 5117289
    [No Abstract]   [Full Text] [Related]  

  • 25. 5-Fluorocytosine--current status with special references to mode of action and drug resistance.
    Polak A
    Contrib Microbiol Immunol; 1977; 4():158-67. PubMed ID: 342192
    [No Abstract]   [Full Text] [Related]  

  • 26. Epipleural cryptococcosis in a patient with Hodgkin's disease: a case report.
    Lomvardias S; Lurie HI
    Sabouraudia; 1972 Nov; 10(3):256-9. PubMed ID: 4565442
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of 5-fluorocytosine in systemic candidiasis in infancy.
    Isacson M; Noah Z; Faber J; Herishano Y; Gottfried L
    Arch Dis Child; 1972 Dec; 47(256):954-9. PubMed ID: 4630479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of urinary candidosis with the oral antifungal drugs 5-fluorocytosine and 'clotrimazole'.
    Holt RJ; Newman RL
    Dev Med Child Neurol Suppl; 1972; 27():70-9. PubMed ID: 4566706
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].
    Sakellarides E
    Schweiz Med Wochenschr; 1981 Sep; 111(37):1367-72. PubMed ID: 7291960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro studies with 5-fluorocytosine.
    Shadomy S
    Appl Microbiol; 1969 Jun; 17(6):871-7. PubMed ID: 5797940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical problems with 5-fluorocytosine.
    Holt RJ
    Mykosen; 1978 Nov; 21(11):363-9. PubMed ID: 740016
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V; Torosantucci A; Simonetti N
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-fluorocytosine in the treatment of cryptococcal meningitis.
    McGill PE; Sequeira R; Jindani A; Nguli ET; Forrester AT; Fulton WF
    East Afr Med J; 1969 Dec; 46(12):663-8. PubMed ID: 5378176
    [No Abstract]   [Full Text] [Related]  

  • 34. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
    Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptococcus neoformans and cryptococcosis.
    Utz JP; Shadomy HJ; Lurie HI
    Trans Am Clin Climatol Assoc; 1970; 81():220-6. PubMed ID: 5521741
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
    Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract]   [Full Text] [Related]  

  • 39. Problems in the diagnosis and treatment of systemic candidiasis.
    Goldstein E; Hoeprich PD
    J Infect Dis; 1972 Feb; 125(2):190-3. PubMed ID: 5007556
    [No Abstract]   [Full Text] [Related]  

  • 40. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
    Böhm W
    Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.